Last reviewed · How we verify

NCT04909619

Suprazygomatic Maxillary Nerve Block in Cleft Palate Outcomes

ENROLLING BY INVITATION NA Last updated 23 May 2025
What this trial tests

NA trial testing Ultrasound-guided bilateral suprazygomatic maxillary nerve block in Cleft Palate Children in 40 participants. Enrolling by invitation.

Timeline
1 March 2021
Primary endpoint
30 June 2025
30 June 2025

Quick facts

Lead sponsorAnn & Robert H Lurie Children's Hospital of Chicago
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment40
Start date1 March 2021
Primary completion30 June 2025
Estimated completion30 June 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Ann & Robert H Lurie Children's Hospital of Chicago

Who can join

Adults 9 Months to 2, any sex, with Cleft Palate Children. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Increased pain after cleft palate surgery is the leading cause of increased hospital length of stay, delayed oral intake, readmission, and respiratory compromise. The goal is to improve all outcomes by identifying the most effective evidenced-based method of intra-operative pain control.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cleft Palate Children

Currently open trials in the same condition.

Other Ann & Robert H Lurie Children's Hospital of Chicago trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04909619.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing